3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors
US4912120A · kind A · utility
27Cited by
7References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 1987 |
| Grant date | Mar 27, 1990 |
| Priority date | — |
| Expiry date | Mar 13, 2007 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06078
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention is directed to certain 3,5 substituted, 4,5-dihydroisoxazoles, and methods for their use. These compounds are transgulatminase inhibitors, and are particularly effective in the inhibition of epidermal transglutaminase and the treatment of acne.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.